Sort
8,912 grants matching “sars cov 2”
Human Monoclonal Antibodies and Antibody-Guided Nanoparticles
$1,257,527Dimiter S Dimitrov · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Immune Tolerance Network
$1,255,142Gerald T Nepom · Benaroya Research Inst At Virginia Mason · UM1 · FY2021 · AI
DNA Replication, Cancer and Chemotherapy
$1,254,803Melvin Depamphilis · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2021 · HD
PPG: SARS-CoV-host cell interactions and vaccine development
$1,254,329Stanley Perlman · University Of Iowa · P01 · FY2021 · AI
PPG: SARS-CoV-host cell interactions and vaccine development
$1,254,329Stanley Perlman · University Of Iowa · P01 · FY2018 · AI
PPG: SARS-CoV-host cell interactions and vaccine development
$1,254,329Stanley Perlman · University Of Iowa · P01 · FY2019 · AI
PPG: SARS-CoV-host cell interactions and vaccine development
$1,254,329Stanley Perlman · University Of Iowa · P01 · FY2020 · AI
CEIRR: SARS-COV-2 Research Activities
$1,251,901S. Mark Tompkins · University Of Georgia · N01 · FY2023 · AI
Clinical Research and Assay Support
$1,251,469Mary Walter · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIC · FY2022 · DK
Neuronal pathogenesis: acute and post-acute implications of viruses
$1,250,286Rahul Suryawanshi · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
India International Center for Excellence in Research
$1,250,220Thomas Nutman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
CLINICAL RESEARCH OPERATIONS AND MANAGEMENT SUPPORT (CROMS): SARS-CoV-2 CLINICAL RESEARCH ACTIVITIES
$1,250,000Melynda Holmes · Technical Resources International, Inc. · N01 · FY2023 · AI
Microfabrication for Biomedical Research
$1,249,808Nicole Y Morgan · National Institute Of Biomedical Imaging And Bioengineering · ZIC · FY2025 · EB
Evolutionary Analysis and Comparative Genomics of Protein Superfamilies
$1,248,690Aravind Iyer · National Library Of Medicine · ZIA · FY2021 · LM
Digital Itap Supplement
$1,246,597David D. McManus · Univ Of Massachusetts Med Sch Worcester · U54 · FY2022 · HL
Natural Products Discovery and Characterization Through Network Collaborations
$1,244,726Lin Du · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Development of broad nanovaccines targeting diverse coronavirus receptor-binding sites
$1,244,471Daniel Kulp · Wistar Institute · P01 · FY2022 · AI
2/2 REPRIEVE Extension for Trial Completion
$1,243,585Michael Tse-Yin Lu · Massachusetts General Hospital · U24 · FY2023 · HL
Yerkes National Primate Research Center Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesis
$1,242,793Jonathan S Lewin · Emory University · P51 · FY2021 · OD
Predictors of Recidivism to Obesity in Weight-Reduced Individuals
$1,239,212Rudolph L Leibel · Columbia University Health Sciences · UH3 · FY2023 · DK
Optimization of a new adaptive intervention to increase COVID-19 testing among people at high risk in an urban community
$1,239,077Liliane Cambraia Windsor · University Of Illinois At Urbana-Champaign · R01 · FY2021 · MD
Study of Pregnancy And Neonatal Health (SPAN)
$1,238,838Edwina Yeung · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2024 · HD
Sin Duda: a community-driven approach to expand reach, access and uptake of COVID-19 home-based tests for at risk Latinos
$1,238,301Kathleen R Page · Johns Hopkins University · U01 · FY2022 · MD
Diagnosing and predicting risk in children with SARS-CoV-2- related illness
$1,238,182Jane C Burns · University Of California, San Diego · R33 · FY2023 · HD
Development of high-performance low field MRI technology
$1,236,724Adrienne Campbell-Washburn · National Heart, Lung, And Blood Institute · ZIA · FY2022 · HL